Targeting the crosstalk of epigenetic modifications and immune evasion in nasopharyngeal cancer

Targeting epigenetic deregulations for the management of esophageal carcinoma: recent advances and emerging approaches

(2023) Parul Ahuja et al.   CELL BIOLOGY AND TOXICOLOGY

Molecular Mechanism of Tocotrienol-Mediated Anticancer Properties: A Systematic Review of the Involvement of Endoplasmic Reticulum Stress and Unfolded Protein Response

(2023) Kok-Lun Pang et al.   Nutrients

Nasopharyngeal Carcinoma Burden and Its Attributable Risk Factors in China: Estimates and Forecasts from 1990 to 2050

(2023) Ruhao Zhang et al.   International Journal of Environmental Research and Public Health

Vitamin E in the management of pancreatic cancer: A scoping review

(2023) Sophia Ogechi Ekeuku et al.   World Journal of Gastrointestinal Oncology

Functional Roles of JNK and p38 MAPK Signaling in Nasopharyngeal Carcinoma

(2022) Lesley Jia Wei Pua et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Regulating Histone Deacetylase Signaling Pathways of Myeloid-Derived Suppressor Cells Enhanced T Cell-Based Immunotherapy

(2022) Adeleye O. Adeshakin et al.   Frontiers in Immunology

A transcriptomic analysis based on aberrant methylation levels revealed potential novel therapeutic targets for nasopharyngeal carcinoma

(2022) Mo Lyu et al.   Annals of Translational Medicine

Targeting pancreatic cancer immune evasion by inhibiting histone deacetylases

(2022) Wynne Sim et al.   WORLD JOURNAL OF GASTROENTEROLOGY

A Novel Inflammatory Response–Related Gene Signature Improves High-Risk Survival Prediction in Patients With Head and Neck Squamous Cell Carcinoma

(2022) Yanxun Han et al.   Frontiers in Genetics

BET bromodomain inhibition rescues PD-1-mediated T-cell exhaustion in acute myeloid leukemia

(2022) Mengjun Zhong et al.   Cell Death & Disease

DNTTIP1 promotes nasopharyngeal carcinoma metastasis via recruiting HDAC1 to DUSP2 promoter and activating ERK signaling pathway

(2022) Shirong Ding et al.   EBioMedicine

Methionine metabolism controls the B cell EBV epigenome and viral latency

(2022) Rui Guo et al.   Cell Metabolism

ESMO–EURACAN Clinical Practice Guideline update for nasopharyngeal carcinoma: adjuvant therapy and first-line treatment of recurrent/metastatic disease

(2022) P. Bossi et al.   ANNALS OF ONCOLOGY

The Role of Deubiquitinating Enzyme in Head and Neck Squamous Cell Carcinoma

(2022) Shengjian Jin et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Epigenomic landscape study reveals molecular subtypes and EBV-associated regulatory epigenome reprogramming in nasopharyngeal carcinoma

(2022) Larry Ka-Yue Chow et al.   EBioMedicine

PBK phosphorylates MSL1 to elicit epigenetic modulation of CD276 in nasopharyngeal carcinoma

(2021) Meng-Yao Wang et al.   Oncogenesis

Efficacy of decitabine plus anti-PD-1 camrelizumab in patients with Hodgkin lymphoma who progressed or relapsed after PD-1 blockade monotherapy

(2021) Chunmeng Wang et al.   CLINICAL CANCER RESEARCH

NLRP3 inflammasome in cancer and metabolic diseases

(2021) Bhesh Raj Sharma et al.   NATURE IMMUNOLOGY

HDAC inhibition potentiates anti-tumor activity of macrophages and enhances anti-PD-L1-mediated tumor suppression

(2021) Xiaolei Li et al.   ONCOGENE

The Role of NK Cells in EBV Infection and EBV-Associated NPC

(2021) Yi Tian Png et al.   Viruses-Basel

IL10 hypomethylation is associated with the risk of gastric cancer

(2021) Junjian Tang et al.   Oncology Letters

Age-dependent changes of gender disparities in nasopharyngeal carcinoma survival

(2021) Wang-Zhong Li et al.   Biology of Sex Differences

The Evolving Epidemiology of Nasopharyngeal Carcinoma

(2021) Ellen T. Chang et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Parallel genome-wide RNAi screens identify lymphocyte-specific protein tyrosine kinase (LCK) as a targetable vulnerability of cell proliferation and chemoresistance in nasopharyngeal carcinoma

(2021) Kitson Liew et al.   CANCER LETTERS

Predictive biomarkers and potential drug combinations of epi-drugs in cancer therapy

(2021) Tianshu Yang et al.   Clinical Epigenetics

Improved clinical outcome in a randomized phase II study of anti-PD-1 camrelizumab plus decitabine in relapsed/refractory Hodgkin lymphoma

(2021) Yang Liu et al.   Journal for ImmunoTherapy of Cancer

Roles of Inflammasomes in Epstein–Barr Virus-Associated Nasopharyngeal Cancer

(2021) Chin King Looi et al.   Cancers

964MO Entinostat, nivolumab and ipilimumab in advanced HER2-negative breast cancer (ETCTN-9844)

(2021) E.T. Roussos Torres et al.   ANNALS OF ONCOLOGY

Simultaneously both expression of LMP-1 and methylation of E-cadherin: Molecular biomarker in stage IV of nasopharyngeal carcinoma patients

(2021) TD Lao et al.   Balkan Journal of Medical Genetics

Phase I Study of Entinostat and Nivolumab with or without Ipilimumab in Advanced Solid Tumors (ETCTN-9844)

(2021) Evanthia T. Roussos Torres et al.   CLINICAL CANCER RESEARCH

A comprehensive analysis of different gene classes in pancreatic cancer: SIGLEC15 may be a promising immunotherapeutic target

(2021) Ji-li Xu et al.   INVESTIGATIONAL NEW DRUGS

Results from the phase Ib of the SENSITIZE trial combining domatinostat with pembrolizumab in advanced melanoma patients refractory to prior checkpoint inhibitor therapy.

(2021) Jessica Cecile Hassel et al.   JOURNAL OF CLINICAL ONCOLOGY

B7-H3/CD276: An Emerging Cancer Immunotherapy

(2021) Wu-Tong Zhou et al.   Frontiers in Immunology

Radiotherapy Combined with PD-1 Inhibition Increases NK Cell Cytotoxicity towards Nasopharyngeal Carcinoma Cells

(2021) Anna Makowska et al.   Cells

The Stromal and Immune Landscape of Nasopharyngeal Carcinoma and Its Implications for Precision Medicine Targeting the Tumor Microenvironment

(2021) Lanqi Gong et al.   Frontiers in Oncology

Molecular Basis of Epstein–Barr Virus Latency Establishment and Lytic Reactivation

(2021) Takayuki Murata et al.   Viruses-Basel

The Epstein-Barr Virus Oncogene EBNA1 Suppresses Natural Killer Cell Responses and Apoptosis Early after Infection of Peripheral B Cells

(2021) Danielle Westhoff Smith et al.   mBio

Multi-Omics Data Analyses Identify B7-H3 as a Novel Prognostic Biomarker and Predict Response to Immune Checkpoint Blockade in Head and Neck Squamous Cell Carcinoma

(2021) Wanzun Lin et al.   Frontiers in Immunology

Epstein–Barr Virus—Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies

(2021) Marcus Bauer et al.   Cancers

Crosstalk Between Inflammatory Signaling and Methylation in Cancer

(2021) Dipanwita Das et al.   Frontiers in Cell and Developmental Biology

An Epigenetic Insight into NLRP3 Inflammasome Activation in Inflammation-Related Processes

(2021) Aroa Baragaño Raneros et al.   Biomedicines

Through Reducing ROS Production, IL-10 Suppresses Caspase-1-Dependent IL-1β Maturation, thereby Preventing Chronic Neuroinflammation and Neurodegeneration

(2020) Yun Gao et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Epigenetic therapy inhibits metastases by disrupting premetastatic niches

(2020) Zhihao Lu et al.   NATURE

Re-epithelialization and immune cell behaviour in an ex vivo human skin model

(2020) Ana Rakita et al.   Scientific Reports

Phase II randomized trial of first-line pembrolizumab and vorinostat in patients with metastatic NSCLC (mNSCLC).

(2020) Andreas Nicholas Saltos et al.   JOURNAL OF CLINICAL ONCOLOGY

Preclinical and clinical studies of a class I/IV HDAC inhibitor, mocetinostat, in melanoma.

(2020) Jeffrey S. Weber et al.   JOURNAL OF CLINICAL ONCOLOGY

Epigenetic lifestyle of Epstein-Barr virus

(2020) Alexander Buschle et al.   Seminars in Immunopathology

The deubiquitinase USP22 regulates PD-L1 degradation in human cancer cells

(2020) Yu Wang et al.   Cell Communication and Signaling

The effects of NLRP3 inflammasome inhibition by MCC950 on LPS-induced pancreatic adenocarcinoma inflammation

(2020) Alan Cheuk Keong Yaw et al.   JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY

Head and Neck Cancers, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology

(2020) David G. Pfister et al.   Journal of the National Comprehensive Cancer Network

Exhausted T cell signature predicts immunotherapy response in ER-positive breast cancer

(2020) Manuela Terranova-Barberio et al.   Nature Communications

Radiation-Induced DNMT3B Promotes Radioresistance in Nasopharyngeal Carcinoma through Methylation of p53 and p21

(2020) Cheng Wu et al.   Molecular Therapy-Oncolytics

Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion

(2020) Li-Lian Gan et al.   Cancers

The Role of Ras-Associated Protein 1 (Rap1) in Cancer: Bad Actor or Good Player?

(2020) Chin-King Looi et al.   Biomedicines

Pan-cancer analysis of NLRP3 inflammasome with potential implications in prognosis and immunotherapy in human cancer

(2020) Mingyi Ju et al.   BRIEFINGS IN BIOINFORMATICS

An epigenetic journey: Epstein-Barr virus transcribes chromatinized and subsequently unchromatinized templates during its lytic cycle

(2019) Adityarup Chakravorty et al.   JOURNAL OF VIROLOGY

BET Inhibition Modifies Melanoma Infiltrating T Cells and Enhances Response to PD-L1 Blockade

(2019) Neda Nikbakht et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Addition of Low-Dose Decitabine to Anti–PD-1 Antibody Camrelizumab in Relapsed/Refractory Classical Hodgkin Lymphoma

(2019) Jing Nie et al.   JOURNAL OF CLINICAL ONCOLOGY

Therapeutic challenges and current immunomodulatory strategies in targeting the immunosuppressive pancreatic tumor microenvironment

(2019) Chin-King Looi et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

The next‐generation BET inhibitor, PLX51107, delays melanoma growth in a CD8‐mediated manner

(2019) Dan A. Erkes et al.   Pigment Cell & Melanoma Research

Nasopharyngeal carcinoma

(2019) Yu-Pei Chen et al.   LANCET

An Evolutionarily Conserved Function of Polycomb Silences the MHC Class I Antigen Presentation Pathway and Enables Immune Evasion in Cancer

(2019) Marian L. Burr et al.   CANCER CELL

Phase I/Ib Study of Pembrolizumab Plus Vorinostat in Advanced/Metastatic Non–Small Cell Lung Cancer

(2019) Jhanelle E. Gray et al.   CLINICAL CANCER RESEARCH

Targeting EZH2 enhances antigen presentation, antitumor immunity and circumvents anti-PD-1 resistance in head and neck cancers

(2019) Liye Zhou et al.   CLINICAL CANCER RESEARCH

USP22 Deubiquitinates CD274 to Suppress Anticancer Immunity

(2019) Xing Huang et al.   Cancer Immunology Research

IL-10 promoter hypomethylation is associated with increased IL-10 expression and poor survival in hepatocellular carcinoma

(2019) Xianjing Zhang et al.   Translational Cancer Research

Viral IL‐10 promotes cell proliferation and cell cycle progression via JAK2/STAT3 signaling pathway in nasopharyngeal carcinoma cells

(2019) Yanxin Ren et al.   BIOTECHNOLOGY AND APPLIED BIOCHEMISTRY

A Phase II Trial of Pembrolizumab and Vorinostat in Recurrent Metastatic Head and Neck Squamous Cell Carcinomas and Salivary Gland Cancer

(2019) Cristina P. Rodriguez et al.   CLINICAL CANCER RESEARCH

Phase II study of CC-486 (oral azacitidine) in previously treated patients with locally advanced or metastatic nasopharyngeal carcinoma

(2019) Ricard Mesia et al.   EUROPEAN JOURNAL OF CANCER

Baicalein inhibits growth of Epstein-Barr virus-positive nasopharyngeal carcinoma by repressing the activity of EBNA1 Q-promoter

(2018) Yaqian Zhang et al.   BIOMEDICINE & PHARMACOTHERAPY

T Cell Dysfunction in Cancer

(2018) Daniela S. Thommen et al.   CANCER CELL

PARP1 Stabilizes CTCF Binding and Chromatin Structure to Maintain Epstein Barr Virus Latency Type

(2018) Lena N. Lupey-Green et al.   JOURNAL OF VIROLOGY

Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumors

(2018) Jooeun Bae et al.   LEUKEMIA

MiR-152 functioning as a tumor suppressor that interacts with DNMT1 in nasopharyngeal carcinoma

(2018) Zhi-Wei Lu et al.   OncoTargets and Therapy

BET bromodomain inhibitor JQ1 preferentially suppresses EBV-positive nasopharyngeal carcinoma cells partially through repressing c-Myc

(2018) Ning Li et al.   Cell Death & Disease

DNMT1 mediates metabolic reprogramming induced by Epstein–Barr virus latent membrane protein 1 and reversed by grifolin in nasopharyngeal carcinoma

(2018) Xiangjian Luo et al.   Cell Death & Disease

Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells

(2018) Luc Gailhouste et al.   Cell Death & Disease

Structural absorption by barbule microstructures of super black bird of paradise feathers

(2018) Dakota E. McCoy et al.   Nature Communications

Targeting EZH2 Reprograms Intratumoral Regulatory T Cells to Enhance Cancer Immunity

(2018) David Wang et al.   Cell Reports

STAT5 and TET2 Cooperate to Regulate FOXP3-TSDR Demethylation in CD4+ T Cells of Patients with Colorectal Cancer

(2018) Hulin Ma et al.   Journal of Immunology Research

Clinicopathologic and prognostic significance of VEGF, JAK2 and STAT3 in patients with nasopharyngeal carcinoma

(2018) Jin-Zhang Cheng et al.   Cancer Cell International

Epigenetic crossroads of the Epstein-Barr virus B-cell relationship

(2018) Thomas C Frost et al.   Current Opinion in Virology

The clinical role of the TME in solid cancer

(2018) Nicolas A. Giraldo et al.   BRITISH JOURNAL OF CANCER

Epstein-Barr Virus miR-BART6-3p Inhibits the RIG-I Pathway

(2017) Yuanjun Lu et al.   Journal of Innate Immunity

Epigenetics and immunotherapy: The current state of play

(2017) Jennifer Dunn et al.   MOLECULAR IMMUNOLOGY

Demographic and clinicopathological characteristics of nasopharyngeal carcinoma and survival outcomes according to age at diagnosis: A population-based analysis

(2017) San-Gang Wu et al.   ORAL ONCOLOGY

Epstein–Barr virus infection and nasopharyngeal carcinoma

(2017) Sai Wah Tsao et al.   PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES

BET Proteins as Targets for Anticancer Treatment

(2017) Anastasios Stathis et al.   Cancer Discovery

PDCD1 (PD-1) promoter methylation predicts outcome in head and neck squamous cell carcinoma patients

(2017) Diane Goltz et al.   Oncotarget

Epstein–Barr virus: a master epigenetic manipulator

(2017) Rona S Scott   Current Opinion in Virology

PD-1 and PD-L1 Checkpoint Signaling Inhibition for Cancer Immunotherapy: Mechanism, Combinations, and Clinical Outcome

(2017) Hashem O. Alsaab et al.   Frontiers in Pharmacology

IL-10: A Multifunctional Cytokine in Viral Infections

(2017) José M. Rojas et al.   Journal of Immunology Research

Diagnostic Capacity of RASSF1A Promoter Methylation as a Biomarker in Tissue, Brushing, and Blood Samples of Nasopharyngeal Carcinoma

(2017) Meng Ye et al.   EBioMedicine

HDAC Inhibitors Enhance T-Cell Chemokine Expression and Augment Response to PD-1 Immunotherapy in Lung Adenocarcinoma

(2016) Hong Zheng et al.   CLINICAL CANCER RESEARCH

Viral IL-10 down-regulates the “MHC-I antigen processing operon” through the NF-κB signaling pathway in nasopharyngeal carcinoma cells

(2016) Yan-xin Ren et al.   CYTOTECHNOLOGY

Epstein-Barr virus mRNA profiles and viral DNA methylation status in nasopharyngeal brushings from nasopharyngeal carcinoma patients reflect tumor origin

(2016) Octavia Ramayanti et al.   INTERNATIONAL JOURNAL OF CANCER

Genetic and Epigenetic Regulation of PD-1 Expression

(2016) Alexander P. R. Bally et al.   JOURNAL OF IMMUNOLOGY

MicroRNA-152 inhibits cell proliferation, migration and invasion by directly targeting MAFB in nasopharyngeal carcinoma

(2016) Yan Li et al.   Molecular Medicine Reports

Stat3 contributes to cancer progression by regulating Jab1/Csn5 expression

(2016) Y Pan et al.   ONCOGENE

Epstein–Barr virus microRNAs reduce immune surveillance by virus-specific CD8+T cells

(2016) Manuel Albanese et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

miR-34b inhibits nasopharyngeal carcinoma cell proliferation by targeting ubiquitin-specific peptidase 22

(2016) Yuhui Tan et al.   OncoTargets and Therapy

Higher methylation intensity induced by EBV LMP1 via NF-κB/DNMT3b signaling contributes to silencing of PTEN gene

(2016) Hong Peng et al.   Oncotarget

Inhibitors of histone deacetylase 1 reverse the immune evasion phenotype to enhance T-cell mediated lysis of prostate and breast carcinoma cells

(2016) Sofia R. Gameiro et al.   Oncotarget

ERK/c-Jun Recruits Tet1 to Induce Zta Expression and Epstein-Barr Virus Reactivation through DNA Demethylation

(2016) Wei Zhang et al.   Scientific Reports

NLRP3 Activation Was Regulated by DNA Methylation Modification duringMycobacterium tuberculosisInfection

(2016) Meili Wei et al.   Biomed Research International

Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study

(2015) Owen A. O'Connor et al.   JOURNAL OF CLINICAL ONCOLOGY

Genome-Wide Identification of a Methylation Gene Panel as a Prognostic Biomarker in Nasopharyngeal Carcinoma

(2015) W. Jiang et al.   MOLECULAR CANCER THERAPEUTICS

Foxp3+ T cells expressing RORγt represent a stable regulatory T-cell effector lineage with enhanced suppressive capacity during intestinal inflammation

(2015) B-H Yang et al.   Mucosal Immunology

Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy

(2015) Dongjun Peng et al.   NATURE

Detection of nasopharyngeal carcinoma in Morocco (North Africa) using a multiplex methylation-specific PCR biomarker assay

(2015) Imran Nawaz et al.   Clinical Epigenetics

HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade

(2015) D. M. Woods et al.   Cancer Immunology Research

Comparative methylome analysis in solid tumors reveals aberrant methylation at chromosome 6p in nasopharyngeal carcinoma

(2015) Wei Dai et al.   Cancer Medicine

Understanding the interplay between host immunity and Epstein-Barr virus in NPC patients

(2015) Yong Shen et al.   Emerging Microbes & Infections

EBV-driven LMP1 and IFN-γ up-regulate PD-L1 in nasopharyngeal carcinoma: Implications for oncotargeted therapy

(2015) Wenfeng Fang et al.   Oncotarget

Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers

(2015) Huili Li et al.   Oncotarget

Chronic TLR Stimulation Controls NLRP3 Inflammasome Activation through IL-10 Mediated Regulation of NLRP3 Expression and Caspase-8 Activation

(2015) Prajwal Gurung et al.   Scientific Reports

Modulation of LMP2A Expression by a Newly Identified Epstein-Barr Virus-Encoded MicroRNA miR-BART22

(2015) Raymond Wai-Ming Lung et al.   NEOPLASIA

Expression of B7-H3, a Potential Factor of Tumor Immune Evasion in Combination with the Number of Regulatory T Cells, Affects Against Recurrence-Free Survival in Breast Cancer Patients

(2014) N. Maeda et al.   ANNALS OF SURGICAL ONCOLOGY

Irradiation and anti–PD-L1 treatment synergistically promote antitumor immunity in mice

(2014) Liufu Deng et al.   JOURNAL OF CLINICAL INVESTIGATION

MicroRNA miR-BART20-5p Stabilizes Epstein-Barr Virus Latency by Directly Targeting BZLF1 and BRLF1

(2014) Y.-J. Jung et al.   JOURNAL OF VIROLOGY

Regulation of Epstein-Barr virus reactivation from latency

(2014) Takayuki Murata   MICROBIOLOGY AND IMMUNOLOGY

Etiological factors of nasopharyngeal carcinoma

(2014) Sai Wah Tsao et al.   ORAL ONCOLOGY

CpG Island Methylator Phenotype, Helicobacter pylori, Epstein-Barr Virus, and Microsatellite Instability and Prognosis in Gastric Cancer: A Systematic Review and Meta-Analysis

(2014) Liang Zong et al.   PLoS One

5-Azacytidine Enhances the Radiosensitivity of CNE2 and SUNE1 Cells In Vitro and In Vivo Possibly by Altering DNA Methylation

(2014) Wei Jiang et al.   PLoS One

Recurrent nasopharyngeal carcinoma: a clinical dilemma and challenge

(2013) Tao Xu et al.   Current Oncology

Innate immune responses against Epstein Barr virus infection

(2013) Obinna Chijioke et al.   JOURNAL OF LEUKOCYTE BIOLOGY

Epigenetic Deregulation of the LMP1/LMP2 Locus of Epstein-Barr Virus by Mutation of a Single CTCF-Cohesin Binding Site

(2013) H.-S. Chen et al.   JOURNAL OF VIROLOGY

Mbd2 Promotes Foxp3 Demethylation and T-Regulatory-Cell Function

(2013) L. Wang et al.   MOLECULAR AND CELLULAR BIOLOGY

Epstein–Barr virus and host cell methylation: regulation of latency, replication and virus reactivation

(2013) Anne Woellmer et al.   Current Opinion in Virology

Epigenetic modification of the Epstein-Barr virus BZLF1 promoter regulates viral reactivation from latency

(2013) Takayuki Murata et al.   Frontiers in Genetics

Cutting Edge: miR-223 and EBV miR-BART15 Regulate the NLRP3 Inflammasome and IL-1  Production

(2012) M. Haneklaus et al.   JOURNAL OF IMMUNOLOGY

Epigenetic Histone Modification of Epstein-Barr Virus BZLF1 Promoter during Latency and Reactivation in Raji Cells

(2012) T. Murata et al.   JOURNAL OF VIROLOGY

Distinct Functional Patterns of Gene Promoter Hypomethylation and Hypermethylation in Cancer Genomes

(2012) Xiaopei Shen et al.   PLoS One

Deciphering the molecular genetic basis of NPC through molecular, cytogenetic, and epigenetic approaches

(2012) Kwok-Wai Lo et al.   SEMINARS IN CANCER BIOLOGY

The EBV Immunoevasins vIL-10 and BNLF2a Protect Newly Infected B Cells from Immune Recognition and Elimination

(2012) Simon Jochum et al.   PLoS Pathogens

BZLF1 Governs CpG-Methylated Chromatin of Epstein-Barr Virus Reversing Epigenetic Repression

(2012) Anne Woellmer et al.   PLoS Pathogens

Chronic Virus Infection Enforces Demethylation of the Locus that Encodes PD-1 in Antigen-Specific CD8+ T Cells

(2011) Ben Youngblood et al.   IMMUNITY

Hypomethylation of the interleukin-10 gene in breast cancer tissues

(2010) Keun Su Son et al.   BREAST

Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors

(2010) Cliona Grant et al.   Expert Review of Anticancer Therapy

CTCF Prevents the Epigenetic Drift of EBV Latency Promoter Qp

(2010) Italo Tempera et al.   PLoS Pathogens

Epigenetics in cancer

(2009) S. Sharma et al.   CARCINOGENESIS

Gamma-Ray Resistance of Regulatory CD4+CD25+Foxp3+T Cells in Mice

(2009) Yanyan Qu et al.   RADIATION RESEARCH

Epigenetic Regulation of Gene Expression in the Inflammatory Response and Relevance to Common Diseases

(2008) Anthony G. Wilson   JOURNAL OF PERIODONTOLOGY